Iodine I 131 in Treating Patients With Thyroid Cancer

Stopped early · Not applicable

Conditions studied: Head and Neck Cancer

In brief

RATIONALE: Radioactive iodine kills thyroid cancer cells by giving off radiation. PURPOSE: This clinical trial is studying the side effects, best dose, and how well iodine I 131 works in treating patients with thyroid cancer.

Key facts

Study ID

NCT00416949

Run by

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

People needed

9

Starts

2006-04-01

Expected to finish

2009-10-01

Last updated by the study team

2018-07-18

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.